Healthcare


 Mayne Pharma's (ASX:MYX) Recent Surge: What’s Driving the Momentum?

Mayne Pharma's (ASX:MYX) Recent Surge: What’s Driving the Momentum?

February 13, 2025 01:51 PM AEDT| By Team Kalkine Media

Highlights,Mayne Pharma (,ASX:MYX,) shares jumped 26% in a month, but long-term performance,remains,moderate.,The company's price-to-sales (P/S) ratio is significantly lower than industry peers.,Revenue growth forecasts,indicate,a slower trajectory c...

 Pro Medicus (ASX: PME) Sees 42.7% Profit Surge, Driven by Major Contracts and Strong Market Growth

Pro Medicus (ASX: PME) Sees 42.7% Profit Surge, Driven by Major Contracts and Strong Market Growth

February 13, 2025 01:00 PM AEDT| By Team Kalkine Media

Highlights,Pro Medicus (ASX: PME) reports a 42.7% increase in net profit for the first half of FY24.,Record-breaking contract wins, including the largest deal in company history worth $330 million.,Company,remains,debt-free with solid cash reserves o...

 Pro Medicus (ASX:PME) Reports Strong HY25 Growth with 43% Profit Surge

Pro Medicus (ASX:PME) Reports Strong HY25 Growth with 43% Profit Surge

February 13, 2025 12:44 PM AEDT| By Team Kalkine Media

Highlights,Revenue jumped 31.1% to $97.2 million,Net profit after tax (NPAT) increased 42.7% to $51.7 million,New and renewed contracts worth over $500 million secured,Pro Medicus (ASX:PME), a leading healthcare technology provider, has delivered an...

 Australian Sharemarket Hits Record High; Sigma (ASX:SIG) Climbs 5% Following Chemist Warehouse Debut

Australian Sharemarket Hits Record High; Sigma (ASX:SIG) Climbs 5% Following Chemist Warehouse Debut

February 13, 2025 12:37 PM AEDT| By Team Kalkine Media

Highlights:,Australian market hits a new record, boosted by positive earnings results.,Sigma (SIG) shares,rise,5% following Chemist Warehouse's public debut.,Materials stocks lead the charge in driving the market's upward movement.,The Australian sto...

 Sigma Healthcare Surges as Chemist Warehouse Debuts on ASX After Major Merger

Sigma Healthcare Surges as Chemist Warehouse Debuts on ASX After Major Merger

February 13, 2025 11:31 AM AEDT| By Team Kalkine Media

Highlights:,Sigma Healthcare's shares rose by 1.8% to $2.81 following the Chemist Warehouse debut on the ASX.,The merger creates one of the largest entities on the Australian bourse, entering the S&P/ASX 100 with a $32 billion market cap.,Chemist War...

 ASX Sees Modest Gains Amid Chemist Warehouse Debut and Sigma’s Strong Performance

ASX Sees Modest Gains Amid Chemist Warehouse Debut and Sigma’s Strong Performance

February 13, 2025 11:28 AM AEDT| By Team Kalkine Media

Highlights,Chemist Warehouse Makes a Strong ASX Debut,: Chemist Warehouse merged with Sigma Healthcare and debuted with a market capitalisation of $31.8 billion, rising 1.8% during its first trading day.,Earnings Drive Market Movement,: Origin Energy...

 Is Wellnex Life Ready for Global Expansion with a Dual Listing?

Is Wellnex Life Ready for Global Expansion with a Dual Listing?

February 13, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Secured commitments amounting to nine million dollars for the AIM dual listing.,Eliminating convertible notes and settling deferred costs from Pain Away results in annual savings exceeding one million dollars.,A non-renounceable entitlemen...

 Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

February 12, 2025 05:22 PM AEDT| By Team Kalkine Media

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

 CSL (ASX:CSL) Faces Mixed Reactions Following First-Half Report and Analyst Adjustments

CSL (ASX:CSL) Faces Mixed Reactions Following First-Half Report and Analyst Adjustments

February 12, 2025 02:11 PM AEDT| By Team Kalkine Media

Highlights,CSL (CSL) shares continue to drop after a 5% loss on Tuesday.,Morningstar raised CSL's fair value estimate by 5%, while adjusting future earnings projections.,Analysts,remain,cautious on CSL’s flu vaccine business but optimistic about its...

 Percheron Therapeutics (ASX:PER) Advances Partnership Talks Amid Strategic Growth Plans

Percheron Therapeutics (ASX:PER) Advances Partnership Talks Amid Strategic Growth Plans

February 12, 2025 12:46 PM AEDT| By Team Kalkine Media

Highlights,Percheron Therapeutics (,ASX:PER,) expects partnership proposals for its phase IIb trial by the end of February.,The company explores new clinical candidates after the ATL1102 study outcome.,Broader strategic partnerships are being conside...

 Dr. Boreham’s Crucible: Why is Biotech Giant CSL Creating Such a Stir?

Dr. Boreham’s Crucible: Why is Biotech Giant CSL Creating Such a Stir?

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

CSL Faces Challenges and Opportunities in Flu Vaccine Market Amidst Diverging Divisional Performance

 Island finishes dosing in the Phase 2b segment of its dengue trial, spread by mosquitoes.

Island finishes dosing in the Phase 2b segment of its dengue trial, spread by mosquitoes.

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights:,Island Pharmaceuticals (ILA) successfully completes Phase 2b trial dosing for ISLA-101, focused on dengue fever treatment.,Results anticipated in the coming weeks, evaluating the drug’s effectiveness in reducing viral levels and symptoms....

 Healthcare leaders in the ASX sector juggle multiple roles within this interconnected industry.

Healthcare leaders in the ASX sector juggle multiple roles within this interconnected industry.

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,ASX healthcare sector leaders frequently engage with multiple companies, providing strategic insight and fostering growth.,Executives like Syntara's Gary Phillips and Dimerix's Dr Nina Webster play pivotal roles in advancing early-stage dr...

 Vitura Health Acquires Telehealth Platform for Medical Cannabis

Vitura Health Acquires Telehealth Platform for Medical Cannabis

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Vitura Health (ASX:VIT) expands its telehealth portfolio by acquiring Candor Medical for $5.9 million.,CSL (ASX:CSL) experiences mixed reactions to its recent financial results, with varying expert opinions.,Percheron Therapeutics (ASX:PER...

 Ansell Limited Mastering Debt Management and Financial Resilience in the Medical Equipment Sector

Ansell Limited Mastering Debt Management and Financial Resilience in the Medical Equipment Sector

February 11, 2025 07:31 PM AEDT| By Team Kalkine Media

Ansell Limited Mastering Debt Management and Financial Resilience in the Medical Equipment Sector

 CSL (ASX:CSL) Shares Fall After Underperforming First-Half Results Amid Vaccine Business Struggles

CSL (ASX:CSL) Shares Fall After Underperforming First-Half Results Amid Vaccine Business Struggles

February 11, 2025 03:41 PM AEDT| By Team Kalkine Media

Highlights,CSL (CSL) misses first-half estimates.,Seqirus vaccine division,impacted,by low influenza,immunisation,rates.,Full-year revenue and NPATA guidance remain unchanged despite,results,.,Shares of CSL (ASX:CSL) experienced a dramatic reversal i...

 Botanix Pharmaceuticals (ASX:BOT) Charting the Road to Operational Stability

Botanix Pharmaceuticals (ASX:BOT) Charting the Road to Operational Stability

February 11, 2025 03:32 PM AEDT| By Team Kalkine Media

Botanix Pharmaceuticals (ASX:BOT) Charting the Road to Operational Stability

 Ramsay Health Care Shares Surge 4.6% on Tuesday. Here's Why.

Ramsay Health Care Shares Surge 4.6% on Tuesday. Here's Why.

February 11, 2025 11:23 AM AEDT| By Team Kalkine Media

Highlights,Ramsay Health Care shares jumped,4.6% to AU$35.81,, their highest level since December 2023.,The company forecasts,1H25 underlying NPAT of AU$150M–AU$160M,, exceeding analyst expectations.,Ramsay flagged a,AU$305M impairment,for its UK seg...

 CSL Shares Edge Higher on Half-Year Results, Targets 10-13% NPATA Growth

CSL Shares Edge Higher on Half-Year Results, Targets 10-13% NPATA Growth

February 11, 2025 11:19 AM AEDT| By Team Kalkine Media

Highlights,CSL shares rose 0.5% to AU$271.68 following the release of its half-year FY25 results.,Revenue grew 5% to US$8.48 billion, while net profit after tax (NPAT) increased 7% in constant currency.,Despite missing consensus estimates, CSL reaffi...

 Citi Raises Ansell Price Target Amid Earnings Update and Upgraded Guidance

Citi Raises Ansell Price Target Amid Earnings Update and Upgraded Guidance

February 11, 2025 11:12 AM AEDT| By Team Kalkine Media

Highlights,Citi increased its price target for Ansell to AU$38, up from AU$32.50.,Ansell’s 1H25 adjusted EPS of 55.7 US cents beat consensus estimates by 9%.,The company upgraded its FY25 EPS forecast and expects further earnings growth from acquisit...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.